Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00QOF
|
||||
Former ID |
DIB000806
|
||||
Drug Name |
ORG-13011
|
||||
Synonyms |
1-[4-[4-[4-(Trifluoromethyl)pyridin-2-yl]piperazin-1-yl]butyl]pyrrolidin-2-one fumarate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Psychotic disorders [ICD9: 290-299; ICD10:F20-F29] | Phase 2 | [521409] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C19H29N5O2
|
||||
Canonical SMILES |
CC1(C)CC(=O)N(CCCCN2CCN(CC2)c3ncccn3)C(=O)C1
|
||||
InChI |
1S/C19H29N5O2/c1-19(2)14-16(25)24(17(26)15-19)9-4-3-8-22-10-12-23(13-11-22)18-20-6-5-7-21-18/h5-7H,3-4,8-15H2,1-2H3
|
||||
InChIKey |
QOIGKGMMAGJZNZ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | Antagonist | [525547], [551871] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.